1. bookVolume 62 (2018): Edizione 1 (March 2018)
Dettagli della rivista
Prima pubblicazione
30 Mar 2016
Frequenza di pubblicazione
4 volte all'anno
Accesso libero

Permeability of the Blood-Brain Barrier and Transport of Nanobodies Across the Blood-Brain Barrier

Pubblicato online: 11 Apr 2018
Volume & Edizione: Volume 62 (2018) - Edizione 1 (March 2018)
Pagine: 59 - 66
Ricevuto: 04 Dec 2017
Accettato: 26 Jan 2018
Dettagli della rivista
Prima pubblicazione
30 Mar 2016
Frequenza di pubblicazione
4 volte all'anno

1. Abbott, N. J., Friedman, A., 2012: Overview and introduction: The blood-brain barrier in health and disease. Epilepsia, 53, 1—6.10.1111/j.1528-1167.2012.03696.x362572823134489Search in Google Scholar

2. Abbott, N. J., 1992: Comparative physiology of the bloodbrain barrier. In Bradbury, M. W. B. (Ed.):Physiology and Pharmacology of the Blood-Brain Barrier, Springer Berlin Heidelberg, 371—396.10.1007/978-3-642-76894-1_15Search in Google Scholar

3. Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., Begley, D. J., 2010: Structure and function of the blood-brain barrier. Neurobiol. Dis., 37, 13—25.10.1016/j.nbd.2009.07.03019664713Apri DOISearch in Google Scholar

4. Abbott, N. J., Ronnback, L., Hansson, E., 2006: Astrocyteendothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci., 7, 41—53.10.1038/nrn182416371949Search in Google Scholar

5. Abulrob, A., Sprong, H., Van Bergen, E., Henegouwen, P., Stanimirovic, D., 2005: The blood-brain barrier transmigrating single domain antibody: Mechanisms of transport and antigenic epitopes in human brain endothelial cells. J. Neurochem., 95, 1201—1214.10.1111/j.1471-4159.2005.03463.x16271053Search in Google Scholar

6. Balda, M. S., Matter, K., 2009: Tight junctions and the regulation of gene expression. Biochem. Biophys. Acta, 1788, 761—767.10.1016/j.bbamem.2008.11.02419121284Apri DOISearch in Google Scholar

7. Begley, D. J., Brightman, M. W., 2003: Structural and functional aspects of the blood-brain barrier. Prog. Drug Res., 61, 39—78.10.1007/978-3-0348-8049-7_214674608Search in Google Scholar

8. Begley, D. J., 2004: ABC transporters and the blood-brain barrier. Curr. Pharm. Des., 10, 1295—1312.10.2174/138161204338484415134482Search in Google Scholar

9. Begley, D. J., 2004: Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther., 104, 29—45.10.1016/j.pharmthera.2004.08.00115500907Apri DOISearch in Google Scholar

10. Bernacki, J., Dobrowolska, A., Nierwinska, K., Malecki, A., 2008: Physiology and pharmacological role of the bloodbrain barrier. Pharmacol. Rep., 60, 600—622.Search in Google Scholar

11. Boado, R. J., Hui, E. K. W., Lu, J. Z., Pardridge, W. M., 2012: Glycemic control and chronic dosing of Rhesus monkeys with a fusion protein of iduronidase and a monoclonal antibody against the human insulin receptor. Drug Metabolism and Disposition, 40, 2021—2025.10.1124/dmd.112.046375346382222822036Apri DOISearch in Google Scholar

12. Carman, C. V., Springer, T. A., 2008: Trans-cellular migration: cell-cell contacts get intimate. Current Opinion in Cell Biology, 20, 533—540.10.1016/j.ceb.2008.05.007Apri DOISearch in Google Scholar

13. Charles, A. Janeway, J., Travers, P., Walport, M., Shlomchik, M. J., 2001: The structure of a typical antibody molecule. In Immunobiology, the Immune System in Health and Disease, 5th edition., Garland Science Publishing, New York, 600 pp.Search in Google Scholar

14. Clark, D. E., 2003: In silico prediction of blood-brain barrier permeation. Drug Discovery Today, 8, 927—933.10.1016/S1359-6446(03)02827-7Search in Google Scholar

15. Comor, L., Dolinska, S., Bhide, K., Pulzova, L., Jiménez-Munguía, I., Bencurova, E., et al., 2017: Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis. Microb. Cell Fact., 16,10.1186/s12934-017-0630-zSearch in Google Scholar

16. Cooper, P. R., Ciambrone, G. J., Kliwinski, C. M., Maze, E., Johnson, L., et al., 2013: Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor. Brain Res., 1534, 13—21.10.1016/j.brainres.2013.08.035Apri DOISearch in Google Scholar

17. Dauchy, S., Miller, F., Couraud, P. O., Weaver, R. J., Weksler, B., Romero, I. A., et al., 2009: Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem. Pharmacol., 77, 897—909.10.1016/j.bcp.2008.11.001Search in Google Scholar

18. Elgert, K. D., 2009:Immunology: Understanding the immune system, 2nd edn., Wiley-Blackwell, New Jersey, 726.Search in Google Scholar

19. Engelhardt, B., Wolburg, H., 2004: Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house ? Eur. J. Immunol., 34, 2955—2963.10.1002/eji.200425327Apri DOISearch in Google Scholar

20. Farrington, G. K., Caram-Salas, N., Haqqani, A. S., Brunette, E., Eldredge, J., Pepinsky, B., et al., 2014: A novel platform for engineering blood-brain barrier-crossing bispecific biologics. FASEB J., 28, 4764—4778.10.1096/fj.14-253369Apri DOISearch in Google Scholar

21. Gaillard, P. J., Brink, A., de Boer, A. G., 2005: Diphtheria toxin receptor-targeted brain drug delivery. Int. Congr. Ser., 1277, 185—198.10.1016/j.ics.2005.02.022Apri DOISearch in Google Scholar

22. Ghassabeh, G. H., Muyldermans, S., Saerens, D., 2010: Nanobodies, single-domain antigen-binding fragments of camelid heavy-chain antibodies. In Shire, S. J., Gombotz, W., Bechtold-Peters, K., Andya, J. (Eds.):Current Trends in Monoclonal Antibody Development and Manufacturing. Springer New York, 29—48.10.1007/978-0-387-76643-0_3Search in Google Scholar

23. Gingrich, M. B., Traynelis, S. F., 2000: Serine proteases and brain damage - is there a link ? Trends Neurosci., 23, 399—407.10.1016/S0166-2236(00)01617-9Apri DOISearch in Google Scholar

24. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hammers, C., Bajyana Songa, E., et al., 1993: Naturally occurring antibodies devoid of light chains. Nature, 363, 446—8.10.1038/363446a08502296Search in Google Scholar

25. Jain, K. K., 2012: Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine, 7, 1225—1233.10.2217/nnm.12.8622931448Apri DOISearch in Google Scholar

26. Li, T., Bourgeois, J. P., Celli, S., Glacial, F., Le Sourd, A. M., Mecheri, S., et al., 2012: Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging. FASEB J., 26, 3969—3979.10.1096/fj.11-20138422730440Apri DOISearch in Google Scholar

27. Lim, D. A., Huang, Y.-C., Alvarez-Buylla, A., 2007: The adult neural stem cell niche: lessons for future neural cell replacement strategies. Neurosurg. Clin. N. Am., 18, 81—92, ix.10.1016/j.nec.2006.10.00217244556Apri DOISearch in Google Scholar

28. Liu, X., Tu, M., Kelly, R. S., Chen, C., Smith, B. J., 2004: Development of a computational approach to predict blood-brain barrier permeability. Drug Metab. Dispos., 32, 132—139.10.1124/dmd.32.1.13214709630Apri DOISearch in Google Scholar

29. McManus, S., Riechmann, L., 1991: Use of 2D NMR, protein engineering, and molecular modelling to study the haptenbinding site of an antibody Fv fragment against 2-phenyloxazolone. Biochemistry, 30, 5851—5857.10.1021/bi00238a0072043627Apri DOISearch in Google Scholar

30. Milenic, D. E., Yokota, T., Filpula, D. R., Finkelman, A. J., Dodd, S. W., Wood, J. F., et al., 1991: Construction, binding properties, metabolism, and tumour targeting of a singlechain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res., 51, 6363—6371.Search in Google Scholar

31. Mitic, L. L., Van Itallie, C. M., Anderson, J M., 2000: Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G250—254.10.1152/ajpgi.2000.279.2.G25010915631Search in Google Scholar

32. Muoio, V., Persson, P. B., Sendeski, M. M., 2014: The neurovascular unit - concept review. Acta Physiol., 210, 790—798.10.1111/apha.1225024629161Search in Google Scholar

33. Muruganandam, A., Tanha, J., Narang, S., Stanimirovic, D., 2002: Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J., 16, 240—242.10.1096/fj.01-0343fje11772942Apri DOISearch in Google Scholar

34. Muyldermans, S., 2013: Nanobodies: natural single-domain antibodies. Annu. Rev. Biochem., 82, 775—797.10.1146/annurev-biochem-063011-09244923495938Apri DOISearch in Google Scholar

35. Nadal, A., Fuentes, E., Pastor, J., McNaughton, P. A., 1995: Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes. Proc. Natl. Acad. Sci. USA, 92, 1426—1430.10.1073/pnas.92.5.1426Apri DOISearch in Google Scholar

36. Nag, S., Begley, D. J., 2005: Blood brain barrier, exchange of metabolites and gases. In Kalimo, H. (Ed.):Pathology and Genetics: Cerebrovascular Diseases. ISN Neuropath. Press, 22—29.Search in Google Scholar

37. Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, A., et al., 2009: A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int., 54, 253—263.10.1016/j.neuint.2008.12.002Search in Google Scholar

38. Padlan, E. A., 1994: Anatomy of the antibody molecule. Mol. Immunol., 31, 169—217.10.1016/0161-5890(94)90001-9Apri DOISearch in Google Scholar

39. Pardridge, W. M., 2012: Drug transport across the bloodbrain barrier. J. Cereb. Blood Flow Metab., 32, 1959—1972.10.1038/jcbfm.2012.126Search in Google Scholar

40. Porter, R. R., 1973: Structural studies of immunoglobulins. Science, 180, 713—716.10.1126/science.180.4087.713Search in Google Scholar

41. Rennels, M. L., Gregory, T. F., Fujimoto, K., 1983: Innervation of capillaries by local neurons in the cat hypothalamus: A light microscopic study with horseradish peroxidase. J. Cereb. Blood Flow Metab., 3, 535—542.10.1038/jcbfm.1983.82Search in Google Scholar

42. Riechmann, L., Cavanagh, J., McManus, S., 1991: Uniform labelling of a recombinant antibody Fv-fragment with 15N and 13C for heteronuclear NMR spectroscopy. FEBS Lett., 287, 185—188.10.1016/0014-5793(91)80047-7Search in Google Scholar

43. Rissiek, B., Koch-Nolte, F., Magnus, T., 2014: Nanobodies as modulators of inflammation: potential applications for acute brain injury. Front. Cell. Neurosci., 8, 344.10.3389/fncel.2014.00344420452125374510Search in Google Scholar

44. Saunders, N. R., Liddelow, S. A., Dziegielewska, K. M., 2012: Barrier mechanisms in the developing brain. Front. Pharmacol., 3, 46.10.3389/fphar.2012.00046331499022479246Search in Google Scholar

45. Smith, Q. R., Rapoport, S. I., 1986: Cerebrovascular permeability coefficients to sodium, potassium, and chloride. J. Neurochem., 46, 1732—42.10.1111/j.1471-4159.1986.tb08491.x3084708Search in Google Scholar

46. Utsumi, S., Karush, F., 1964: The subunits of purified rabbit antibody. Biochemistry, 3, 1329—1338.10.1021/bi00897a024Apri DOISearch in Google Scholar

47. Wang, D., El-Amouri, S. S., Dai, M., Kuan, C. Y., Hui, D. Y., Brady, R. O., et al., 2013: Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier. Proc. Natl. Acad. Sci. USA, 110, 2999—3004.10.1073/pnas.1222742110Search in Google Scholar

48. Wolburg, H., Lippoldt, A., 2002: Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol., 38, 323—337.10.1016/S1537-1891(02)00200-8Search in Google Scholar

49. Wolburg, H., Noell, S., Mack, A., Wolburg-Buchholz, K., Fallier-Becker, P., 2009: Brain endothelial cells and the gliovascular complex. Cell Tissue Res., 335, 75—96.10.1007/s00441-008-0658-918633647Search in Google Scholar

50. Wolburg, H., Wolburg-Buchholz, K., Engelhardt, B., 2005: Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol., 109, 181—190.10.1007/s00401-004-0928-x15549331Search in Google Scholar

51. Wu, A. M., Senter, P. D., 2005: Arming antibodies: prospects and challenges for immunoconjugates. Nat. Biotechnol., 23, 1137—1146.10.1038/nbt114116151407Apri DOISearch in Google Scholar

52. Xiao, G., Gan, L.-S., 2013: Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int. J. Cell Biol., 2013, 14.10.1155/2013/703545369309923840214Search in Google Scholar

53. Yokota, T., Milenic, D. E., Whitlow, M., Schlom, J., 1992: Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52, 3402—3408.Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo